Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The case for inpatient initiation of antiarrhythmic therapy.
Myerburg RJ, Kloosterman M, Yamamura K, Mitrani R, Interian A Jr, Castellanos A. Myerburg RJ, et al. J Cardiovasc Electrophysiol. 1999 Mar;10(3):482-7. doi: 10.1111/j.1540-8167.1999.tb00702.x. J Cardiovasc Electrophysiol. 1999. PMID: 10210516 Review. No abstract available.
Non-influence of lipid lowering therapy in atrial fibrillation recurrence.
Mehta K, Grover PM, Shah N, Patel NJ, Chothani A, Singh V, Savani GT, Deshmukh A, Rathod A, Patel N, Panaich SS, Arora S, Nalluri N, Khalpada D, Bhalaria V, Parmar NG, Badheka AO, Viles-Gonzalez JF, Mitrani RD. Mehta K, et al. Among authors: mitrani rd. Int J Cardiol. 2013 Oct 12;168(5):5006-7. doi: 10.1016/j.ijcard.2013.07.119. Epub 2013 Aug 13. Int J Cardiol. 2013. PMID: 23953261 Clinical Trial. No abstract available.
In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.
Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K, Grover P, Singh V, Vallurupalli S, Savani GT, Badheka A, Tuliani T, Dabhadkar K, Dibu G, Reddy YM, Sewani A, Kowalski M, Mitrani R, Paydak H, Viles-Gonzalez JF. Deshmukh A, et al. Circulation. 2013 Nov 5;128(19):2104-12. doi: 10.1161/CIRCULATIONAHA.113.003862. Epub 2013 Sep 23. Circulation. 2013. PMID: 24061087
Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.
Patel NJ, Hoosien M, Deshmukh A, Badheka AO, Grover PM, Shah N, Singh V, Mehta K, Chothani A, Savani GT, Arora S, Bhalara V, Patel N, Khalpada D, Rathod A, Vazzana TJ, Lafferty J, Viles-Gonzalez JF, Mitrani RD. Patel NJ, et al. Among authors: mitrani rd. Int J Cardiol. 2013 Nov 20;169(5):e84-6. doi: 10.1016/j.ijcard.2013.10.040. Int J Cardiol. 2013. PMID: 24377111 No abstract available.
Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy.
Badheka AO, Shah N, Grover PM, Patel NJ, Chothani A, Mehta K, Singh V, Deshmukh A, Savani GT, Rathod A, Panaich SS, Patel N, Arora S, Bhalara V, Coffey JO, Mitrani RD, Halperin JL, Viles-Gonzalez JF. Badheka AO, et al. Among authors: mitrani rd. Am J Cardiol. 2014 Apr 1;113(7):1159-65. doi: 10.1016/j.amjcard.2013.12.021. Epub 2014 Jan 14. Am J Cardiol. 2014. PMID: 24507168 Clinical Trial.
98 results